Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunochromatography Quantifies Prostate Specific Antigen

By LabMedica International staff writers
Posted on 18 Jan 2012
A fluorescence immunochromatography method using monoclonal antibodies to prostate specific antigen (PSA) has been developed.

The fluorescence immunochromatographic analysis system is composed of anti-PSA-monoclonal antibody (mAb), fluorescence conjugates in a detection solution, a immunochromatographic assay strip, and a laser fluorescence scanner.

Scientists at Kangwon National University (Chuncheon, Korea) have developed a fluorescence immunochromatographic assay strip consists of a nitrocellulose membrane, a sample pad, an absorption pad, and a backing card. The fluorescence immunochromatographic-analysis system was employed to detect PSA based on the area ratio between the control line and the test line of the strip. The test line on the nitrocellulose membrane was dispensed with anti-PSA-mAb; the detection solution was a mixture of anti-PSA-mAb- fluorescent (FL) conjugate and biotin-bovine serum albumin (BSA)-FL conjugate.

Serum obtained from a healthy man, was spiked with PSA to produce five different concentrations: 0.72 ng/mL, 2.3 ng/mL, 4.6 ng/mL, 11.5 ng/mL, 23 ng/mL. These five human sera samples when applied on to the fluorescence immunochromatographic strip which detected PSA concentrations in the human sera samples correlating consistently with the assumed vales. The optimum incubation time of test samples would be exactly 20 minutes, since the standard curve data stored in the fluorescence scanner would be obtained with an incubation time of 20 minutes.

Prostate-specific monoclonal antibody (anti-PSA-mAb) was supplied by Boditech. (Chuncheon, Korea), and prostate-specific antigen (PSA) was obtained from Sigma Aldrich (St. Louis, MO, USA). Under optimal conditions, the area ratio was proportional to PSA concentration ranged from the lowest detection limit of 0.72 ng/mL to 46.0 ng/mL. The authors concluded that as the fluorescence immunochromatography assay is easy to perform and its quantitative range is within PSA concentrations in human blood samples, it shows a potential to be a powerful tool in quantitative analysis of PSA in human blood samples. The study was published in October 2010 in the Journal of Immunoassay and Immunochemistry.

Related Links:
Kangwon National University
Boditech
Sigma Aldrich


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Coagulation Analyzer
CS-2400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.